• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于竞争性内源性网络探索膀胱癌的预后生物标志物。

Explore prognostic biomarker of bladder cancer based on competing endogenous network.

机构信息

Department of Urology, the First Hospital of Jilin University, Changchun 130021, Jilin, China.

Key Laboratory of Pathobiology, Ministry of Education, Jilin University, Changchun 130021, Jilin, China.

出版信息

Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20202463.

DOI:10.1042/BSR20202463
PMID:33169791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7711062/
Abstract

Bladder cancer (BC) is the most common tumor of the urinary tract. Increasing evidence showed that long non-coding RNA (lncRNA) is a critical regulator in cancer development and progression. However, the functions of lncRNAs in the development of BC remain mostly undefined. In the present study, based on RNA sequence profiles from The Cancer Genome Atlas database, we identified 723 lncRNAs, 157 miRNAs, and 1816 mRNAs aberrantly expressed in BC tissues. A competing endogenous RNA network, including 49 lncRNAs, 17 miRNAs, and 36 mRNAs, was then established. The functional enrichment analyses showed that the mRNAs in the ceRNA network mainly participated in 'regulation of transcription' and 'pathways in cancer'. Moreover, the Cox regression analyses demonstrated that three lncRNAs (AC112721.1, TMPRSS11GP, and ADAMTS9-AS1) could serve as independent risk factors. We established a risk prediction model with these lncRNAs. Kaplan-Meier curve analysis showed that high-risk patients' prognosis was lower than that of low-risk patients (P=0.001). The present study provides novel insights into the lncRNA-mediated ceRNA network and the potential of lncRNAs to be candidate prognostic biomarkers in BC, which could help better understand the pathological changes and pathogenesis of BC and be useful for clinical studies in the future.

摘要

膀胱癌(BC)是最常见的泌尿道肿瘤。越来越多的证据表明,长非编码 RNA(lncRNA)是癌症发展和进展的关键调节因子。然而,lncRNAs 在 BC 发展中的功能仍大多未被定义。在本研究中,我们基于来自癌症基因组图谱数据库的 RNA 序列图谱,鉴定了 723 个 lncRNA、157 个 miRNA 和 1816 个在 BC 组织中异常表达的 mRNAs。然后建立了一个竞争内源性 RNA 网络,包括 49 个 lncRNA、17 个 miRNA 和 36 个 mRNAs。功能富集分析表明,ceRNA 网络中的 mRNAs 主要参与“转录调控”和“癌症途径”。此外,Cox 回归分析表明,三个 lncRNA(AC112721.1、TMPRSS11GP 和 ADAMTS9-AS1)可以作为独立的危险因素。我们建立了一个基于这些 lncRNAs 的风险预测模型。Kaplan-Meier 曲线分析表明,高风险患者的预后低于低风险患者(P=0.001)。本研究为 lncRNA 介导的 ceRNA 网络提供了新的见解,并为 lncRNA 作为 BC 潜在的候选预后生物标志物提供了可能性,这有助于更好地理解 BC 的病理变化和发病机制,并为未来的临床研究提供帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/954f19573dba/bsr-40-bsr20202463-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/b501b3157f77/bsr-40-bsr20202463-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/b5f35c8892dc/bsr-40-bsr20202463-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/7f687c0cf8d3/bsr-40-bsr20202463-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/bacf1cafadc6/bsr-40-bsr20202463-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/954f19573dba/bsr-40-bsr20202463-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/b501b3157f77/bsr-40-bsr20202463-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/b5f35c8892dc/bsr-40-bsr20202463-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/7f687c0cf8d3/bsr-40-bsr20202463-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/bacf1cafadc6/bsr-40-bsr20202463-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1519/7711062/954f19573dba/bsr-40-bsr20202463-g5.jpg

相似文献

1
Explore prognostic biomarker of bladder cancer based on competing endogenous network.基于竞争性内源性网络探索膀胱癌的预后生物标志物。
Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20202463.
2
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.系统分析 lncRNA-miRNA-mRNA 竞争内源性 RNA 网络鉴定出四个 lncRNA 特征作为乳腺癌的预后生物标志物。
J Transl Med. 2018 Sep 27;16(1):264. doi: 10.1186/s12967-018-1640-2.
3
Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.对喉鳞状细胞癌中lncRNAs、mRNAs和miRNAs的差异表达谱进行综合分析,以构建ceRNA网络并鉴定潜在生物标志物。
J Cell Biochem. 2019 Oct;120(10):17963-17974. doi: 10.1002/jcb.29063. Epub 2019 May 24.
4
A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify as an Oncogenic lncRNA in Bladder Cancer.竞争内源性 RNA 网络和 8 个长链非编码 RNA 预后标志物将鉴定为膀胱癌中的致癌长链非编码 RNA。
DNA Cell Biol. 2021 Jan;40(1):26-35. doi: 10.1089/dna.2020.6014. Epub 2020 Dec 2.
5
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.基于癌症基因组图谱(TCGA)数据库的膀胱癌 mRNA 表达和内源性 RNA 谱特征分析。
Med Sci Monit. 2019 Apr 25;25:3041-3060. doi: 10.12659/MSM.915487.
6
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.构建 ceRNA 调控网络作为膀胱癌的预后生物标志物。
J Cell Mol Med. 2020 May;24(9):5375-5386. doi: 10.1111/jcmm.15193. Epub 2020 Mar 31.
7
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
8
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.肺鳞状细胞癌中预后相关 lncRNAs、miRNAs 和 mRNAs 形成竞争内源性 RNA 网络的全基因组分析。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1711-1723. doi: 10.1007/s00432-020-03224-8. Epub 2020 Apr 30.
9
Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.鉴定和验证与免疫相关的长链非编码 RNA 标志物,用于预测膀胱癌患者的预后。
Int Immunopharmacol. 2021 Jan;90:107146. doi: 10.1016/j.intimp.2020.107146. Epub 2020 Nov 11.
10
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.舌鳞状细胞癌中 lncRNA-miRNA-mRNA ceRNA 网络的综合分析。
BMC Cancer. 2019 Aug 7;19(1):779. doi: 10.1186/s12885-019-5983-8.

引用本文的文献

1
Application of Protein-Protein Interaction Network Analysis in Order to Identify Cervical Cancer miRNA and mRNA Biomarkers.应用蛋白质-蛋白质相互作用网络分析来鉴定宫颈癌 miRNA 和 mRNA 生物标志物。
ScientificWorldJournal. 2023 Sep 14;2023:6626279. doi: 10.1155/2023/6626279. eCollection 2023.
2
Identification of S100A9 as a Potential Inflammation-Related Biomarker for Radiation-Induced Lung Injury.鉴定S100A9作为辐射诱导肺损伤潜在的炎症相关生物标志物
J Clin Med. 2023 Jan 17;12(3):733. doi: 10.3390/jcm12030733.
3
LncRNA GAS5 regulates the Wnt/β-catenin pathway through the miR-18a-5p/AXIN2/GSK3β axis to inhibit the proliferation and migration of bladder cancer cells.

本文引用的文献

1
Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options.一线治疗晚期尿路上皮癌的临床证据:当前范例和新兴治疗选择。
Cancer Treat Rev. 2020 Sep;89:102072. doi: 10.1016/j.ctrv.2020.102072. Epub 2020 Jul 22.
2
To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.构建 ceRNA 调控网络作为膀胱癌的预后生物标志物。
J Cell Mol Med. 2020 May;24(9):5375-5386. doi: 10.1111/jcmm.15193. Epub 2020 Mar 31.
3
Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network.
长链非编码 RNA GAS5 通过 miR-18a-5p/AXIN2/GSK3β 轴调控 Wnt/β-catenin 通路抑制膀胱癌细胞的增殖和迁移。
Carcinogenesis. 2022 Dec 31;43(12):1176-1189. doi: 10.1093/carcin/bgac087.
4
Integrated Analysis of ceRNA Network to Reveal Potential Prognostic Biomarkers for Glioblastoma.ceRNA网络的综合分析以揭示胶质母细胞瘤潜在的预后生物标志物
Front Genet. 2022 Feb 14;12:803257. doi: 10.3389/fgene.2021.803257. eCollection 2021.
基于 ceRNA 调控网络构建的膀胱癌相关特征生物分子的筛选
World J Urol. 2020 Nov;38(11):2835-2847. doi: 10.1007/s00345-020-03086-2. Epub 2020 Feb 14.
4
miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.微小RNA-302a通过靶向NFIB和CD44抑制结直肠癌的转移和西妥昔单抗耐药性。
Theranostics. 2019 Oct 22;9(26):8409-8425. doi: 10.7150/thno.36605. eCollection 2019.
5
miRNA-29b Inhibits Prostate Tumor Growth and Induces Apoptosis by Increasing Bim Expression.miRNA-29b 通过增加 Bim 表达抑制前列腺肿瘤生长并诱导细胞凋亡。
Cells. 2019 Nov 18;8(11):1455. doi: 10.3390/cells8111455.
6
Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.长链非编码RNA ASLNC07322在结肠癌转移过程中由Smad4调控的VEGF-C表达中发挥作用。
Mol Ther Nucleic Acids. 2019 Dec 6;18:851-862. doi: 10.1016/j.omtn.2019.10.012. Epub 2019 Oct 18.
7
LncRNA CACS15 accelerates the malignant progression of ovarian cancer through stimulating EZH2-induced inhibition of APC.长链非编码RNA CACS15通过刺激EZH2诱导的APC抑制来加速卵巢癌的恶性进展。
Am J Transl Res. 2019 Oct 15;11(10):6561-6568. eCollection 2019.
8
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism.致癌信号与癌症代谢交界处的 PI3K-AKT 网络。
Nat Rev Cancer. 2020 Feb;20(2):74-88. doi: 10.1038/s41568-019-0216-7. Epub 2019 Nov 4.
9
MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.MATN1-AS1 通过作为 miR-200b/c/429 的 ceRNA 来调节 CHD1 表达,从而促进神经胶质瘤的进展。
Cell Prolif. 2020 Jan;53(1):e12700. doi: 10.1111/cpr.12700. Epub 2019 Oct 30.
10
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.丝裂原活化蛋白激酶(MAPK)的全面综述:癌症中一个有前景的治疗靶点
Cancers (Basel). 2019 Oct 22;11(10):1618. doi: 10.3390/cancers11101618.